Aehr Test Valuation
| AEHR Stock | USD 16.45 1.38 9.16% |
At this time, the firm appears to be fairly valued. Aehr Test Systems shows a prevailing Real Value of $14.74 per share. The current price of the firm is $16.45. Our model approximates the value of Aehr Test Systems from analyzing the firm fundamentals such as profit margin of 0.37 %, and Return On Equity of 0.22 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Aehr Test's valuation include:
Price Book 3.6644 | Enterprise Value | Enterprise Value Ebitda 29.8081 | Price Sales 7.3236 | Enterprise Value Revenue 7.4031 |
Fairly Valued
Today
Please note that Aehr Test's price fluctuation is somewhat reliable at this time. Calculation of the real value of Aehr Test Systems is based on 3 months time horizon. Increasing Aehr Test's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aehr stock is determined by what a typical buyer is willing to pay for full or partial control of Aehr Test Systems. Since Aehr Test is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aehr Stock. However, Aehr Test's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.45 | Real 14.74 | Target 11.5 | Hype 16.01 | Naive 14.91 |
The intrinsic value of Aehr Test's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aehr Test's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aehr Test Systems helps investors to forecast how Aehr stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aehr Test more accurately as focusing exclusively on Aehr Test's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Aehr Test's intrinsic value based on its ongoing forecasts of Aehr Test's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Aehr Test's closest peers.
Aehr Test Cash |
|
Aehr Valuation Trend
Aehr Test's real value is important for investors to make better decisions and a more accurate overall view of Aehr Test's financial worth over time. Using both Aehr Test's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Aehr Revenue by Product
Aehr Test Total Value Analysis
Aehr Test Systems is presently forecasted to have valuation of 436.55 M with market capitalization of 450.25 M, debt of 10.83 M, and cash on hands of 30.05 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Aehr Test fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
436.55 M | 450.25 M | 10.83 M | 30.05 M |
Aehr Test Investor Information
About 66.0% of the company shares are held by institutions such as insurance companies. The book value of Aehr Test was presently reported as 4.11. The company recorded a loss per share of 0.13. Aehr Test Systems had not issued any dividends in recent years. Based on the key indicators related to Aehr Test's liquidity, profitability, solvency, and operating efficiency, Aehr Test Systems is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Aehr Test Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Aehr connotes not a very effective usage of assets in July.Aehr Test Ownership Allocation
Aehr Test holds a total of 29.88 Million outstanding shares. Over half of Aehr Test's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Aehr Test Profitability Analysis
The company reported the previous year's revenue of 58.97 M. Net Loss for the year was (3.91 M) with profit before overhead, payroll, taxes, and interest of 28.11 M.About Aehr Test Valuation
The stock valuation mechanism determines Aehr Test's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Aehr Test Systems based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aehr Test. We calculate exposure to Aehr Test's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aehr Test's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 23.9 M | 12.3 M | |
| Pretax Profit Margin | (0.07) | (0.08) | |
| Operating Profit Margin | (0.10) | (0.10) | |
| Net Loss | (0.07) | (0.07) | |
| Gross Profit Margin | 0.41 | 0.32 |
Aehr Test Growth Indicators
Investing in growth stocks can be very risky. If the company such as Aehr Test does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 29.6 M | |
| Quarterly Earnings Growth Y O Y | -0.875 |
Aehr Test Current Valuation Indicators
Aehr Test's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Aehr Test's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Aehr Test, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Aehr Test's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Aehr Test's worth.Additional Tools for Aehr Stock Analysis
When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.